დასაწყისი · კატალოგი · პროფილი · ცხრილი
ჯანდაცვა BODY HANDBOOK
ჯანდაცვა · §609
Barrier Contraception
The recurring background loop — the late-period spiral, the new-partner first-night freight, the should-I-have-used-something thought running an hour after sex — quiets or stops once a barrier is in the routine. Condoms are the only contraceptive that handles HIV and unplanned pregnancy in the same act, with no prescription, no hormones touched, no waiting period the month a reader decides to try for a kid. The honest catch sits in one gap: roughly 2% one-year pregnancy rate when used every time and exactly right, 13-18% in the lives of typical users Trussell 2011. The real decision is rarely barriers versus something else — it is which pieces to layer.
გააკეთე · საჭიროებისამებრ მტკიცებულება ძლიერი თავი ჯანდაცვა

The evidence is as settled as health evidence gets — decades of trials, every major public health body aligned. The cost is small (a few cents to a dollar per use, free at most clinics), the effort is real but lives per act, and the lever the entry uniquely pulls is infection cover: every other contraceptive leaves the STI question open.

A barrier method is exactly what it sounds like: a piece of latex, polyisoprene, polyurethane, or silicone sitting between sperm and ovum, or between one person's genital mucosa and another's. The external (male) condom unrolls over the erect penis and forms a fluid-tight reservoir at the tip. The internal (female) condom is a pre-lubricated nitrile sheath that lines the vagina or rectum, held by a ring at each end. The diaphragm and the cervical cap are silicone cups that sit against the cervix and physically cover the opening, used with a spermicide that immobilises any sperm that get past the rim. The contraceptive sponge is a polyurethane disc soaked in spermicide that does the same job for a 24-hour window. The dental dam is a square of latex used as a barrier during oral-genital contact.

The materials matter. Latex and polyisoprene are impermeable to sperm and to every sexually transmitted virus and bacterium at intact-membrane scales — including HIV (~100 nm) and hepatitis B (~42 nm) Holmes et al. 2004. Polyurethane is also impermeable but is thinner and breaks more often. Lambskin condoms — sold as natural-membrane, marketed as premium — have pores large enough to pass viruses; they prevent pregnancy but not infection. The word natural on the box reverses the correct ranking on STI protection.

What the numbers actually say

Two questions, two answers. Pregnancy prevention is the question the box answers loudly and the literature has been chewing on for forty years. The central finding is the gap between perfect use and typical use — the device on a test bench versus the device in the lives of real users. The condom is excellent on the first reading and mid-tier on the second; both are honest numbers and which one applies to a reader depends entirely on what they actually do.

Infection prevention is the question other contraceptives can't answer at all. The evidence here is dense and tracks a transmission-mode gradient: pathogens that travel in fluid through urethral or vaginal mucosa get blocked completely by an intact barrier, and pathogens that travel by skin contact at uncovered surfaces reduce in proportion to the area the barrier does cover. The numbers, summarised by the WHO Bulletin's review Holmes et al. 2004: consistent condom use cuts HIV transmission by roughly 80-95%, gonorrhea, chlamydia, and trichomoniasis by 50-90%, HSV-2 by 30-50%, and HPV by 40-70%.

Two specific replications worth naming. Weller and Davis-Beaty's Cochrane review of HIV-serodiscordant heterosexual couples found an 80% reduction in HIV incidence with consistent use — and no statistically detectable benefit with inconsistent use. Smith et al. 2015 reproduced the same pattern in men who have sex with men: ~70% reduction with consistent use, no benefit otherwise. The consistency cliff is real; it is the central operational fact about how this method works.

For HPV — the infection roughly 80% of sexually active adults will pick up at some point and the one most readers worry about least — the cleanest data come from Winer et al. 2006, an NEJM prospective cohort of college women newly starting sex with a partner who used condoms every time. They picked up HPV at a 70% lower rate than women whose partners used them less than 5% of the time. The non-zero residual reflects HPV's ability to transmit from skin the condom doesn't cover.

What keeps happening without one

For the sexually active reader who isn't running a barrier and doesn't have a non-barrier method covering both pregnancy and infection, the background risks compound across the years, slowly, and mostly out of sight.

The pregnancy math is simple. With no contraception at all, a fertile couple having sex regularly will see roughly an 85% one-year pregnancy rate — that's the baseline against which every contraceptive failure rate is measured. The reader's lived version of that is a late-period scare every few cycles, an occasional pregnancy test in a gas-station bathroom, and the actual conversation about an actual positive at some point inside a few years.

The infection math is harder to feel because most of it is silent. Chlamydia and gonorrhea often don't produce symptoms in either partner; they're caught when a screen comes back positive, or when one partner develops pelvic pain that traces back to ascending infection a few months later. HPV runs even quieter — the strains most people pick up clear within a couple of years and never produce a visible event, but a slice of exposures persist into the cells of the cervix, the throat, or the anus and produce dysplasia that an annual screen catches and treats, or the cancer it would have become a decade later. HSV-2 announces itself with one bad outbreak and then settles in for life. Syphilis runs through three quiet stages before the late one. HIV, in the higher-prevalence corners of the population, is the one with mortality measured in years lost.

None of these is the dramatic next-week event. They are the background distribution the reader sits in, with the probability they personally land on the bad side scaling with the time they spend in it unprotected and with the partner network they sit inside. The reader who has been having unprotected sex for a decade has rolled the dice on every one of these for a decade.

How to actually use one

The gap between perfect-use and typical-use numbers is mostly user error: condoms put on after sex has already started, removed before it's over, paired with the wrong lubricant, kept in a hot wallet for a year. The protocol below is the per-act version that closes that gap.

One step worth singling out because nearly all the unintended pregnancies in clinic counselling traces to it: the condom goes on before any genital contact, not at the last moment before climax. Pre-ejaculate carries enough sperm to cause pregnancy in a real fraction of cases, and any STI-bearing fluid is on the urethral mucosa from the start.

What most guides quietly get wrong

The perfect-use number is not the relevant number. Most counselling, most box copy, and a lot of school sex-ed quote 2% as if it were the rate the reader is signing up for. The 13-18% typical-use number is the rate; it describes humans across a year, not a condom on a test bench. A reader who is told 2% and then has a scare reads the scare as personal failure — they thought they were the device on the test bench. They were the human, like everyone else.

Doubling up is the opposite of safer. Two condoms at once — or one external paired with one internal — increases friction, increases breakage, and does not stack protection. CDC and WHO both advise specifically against it.

Withdrawal plus a condom is not an upgrade. The condom's pregnancy-prevention math already assumes ejaculate enters the reservoir; pulling out doesn't add anything except a higher chance of breaking the seal during withdrawal.

"Natural" condoms aren't. Lambskin (natural-membrane) condoms have pores that pass viruses. They prevent pregnancy at roughly the rate of latex condoms; they don't prevent HIV, HPV, herpes, hepatitis B, or any other viral STI. The premium price tag inverts the safety ranking.

Spermicide-coated condoms don't add efficacy. The spermicide is nonoxynol-9, which irritates vaginal and rectal mucosa with frequent use and, in high-frequency users, increases HIV transmission rather than reducing it Wilkinson et al. 2002. The plain condom is the safer choice; the coated one was a market convention, not a clinical recommendation.

"He's been tested" is not a substitute. Most STIs have a window period — the time between exposure and detectable result — that runs weeks (chlamydia, gonorrhea) to months (HIV antibody, HPV). A negative test taken last week reflects nothing about exposures since.

Where this goes wrong in practice

The cleanest mapping of how typical use happens — and how it diverges from perfect use — comes from Crosby et al. 2002, a three-month diary study of college men using condoms. The findings reproduce across every adult and clinic replication since:

  • 40% reported putting the condom on after sex had already started, at least once.
  • 15% reported taking it off before sex ended.
  • 30% reported breakage or slippage in the prior three months.
  • 13% reported reusing a condom.

None of these is a device-defect story. Laboratory breakage of latex condoms is around 0.4% per act; real-world breakage and slippage combined hit 2-4% per act, and the difference is almost entirely how people actually do it: oil-based lubricant, the wrong size, storage in a hot wallet, hurried application in a state where attention to detail is the first casualty.

The most common failure isn't a tear — it's the condom that didn't get used. The condom in the medicine cabinet two rooms away didn't protect the act in the bedroom. The condom no one wanted to break the rhythm to put on didn't protect anything either. Storage that's actually reachable — the bedside drawer, an accessible pocket — and a relationship-level conversation about consistency before it gets tested in the moment are the highest-leverage interventions in the literature.

For the diaphragm, cervical cap, and sponge, failure concentrates around insertion: incorrect placement, displacement during intercourse, removal before the six-hour post-coital window. The cervical cap and sponge perform meaningfully worse in women who have given birth vaginally, because the cervix changes shape and the device seats less reliably Trussell 2011.

How this fits with everything else

The contraceptive menu, ranked by typical-use pregnancy failure across a year: implant 0.05%, IUD 0.2-0.8%, injection 4%, pill/ring/patch 7%, external condom 13-18%, withdrawal 20%, spermicide alone 28%, fertility-awareness 15-25% Trussell 2011. On pregnancy alone, barriers are mid-tier. Two long-acting reversible methods — the IUD and the implant — are an order of magnitude more reliable per year.

What none of those alternatives do is cover infection. Every method on that list other than the condom and its siblings leaves the STI question untouched. So the right framing for most readers is not which one; it is which combination:

  • Casual or new partner — barrier, every act, until both partners have tested through the relevant window periods. Pregnancy and infection are both live.
  • Long-term partner, infection question settled, pregnancy still on the table — a LARC (IUD or implant) is the leverage move; it puts pregnancy in the 0.2-0.8% range and the barrier comes off the critical path.
  • Long-term partner, hormones-on-the-table or hormones-off-the-table — barriers are the only hormone-free, immediately-reversible method that delivers reasonable pregnancy prevention. Pair with a fertility-awareness practice or a copper IUD if the typical-use number is too loose for the stakes.
  • Trying to conceive in a few months — barriers in the meantime; no washout period, no waiting cycle for fertility to return.

For HIV specifically: pre-exposure prophylaxis (PrEP, daily tenofovir-based regimens) has changed the calculation for higher-risk users in the last decade. PrEP doesn't cover bacterial STIs or pregnancy; condoms remain the only single intervention that handles HIV plus the bacterial infections in the same act.

External condoms run roughly thirty cents to a dollar each at retail, and are free at most US health departments, college health services, and Planned Parenthood; ministries of health distribute them free in much of the world. A typical user buying their own goes through fifteen to fifty dollars a year. Internal condoms are pricier ($2-4 each) and less reliably stocked. The diaphragm and cervical cap need a fitting visit (around $50-100) and replacement every one to two years, plus a tube of spermicide every couple of months WHO 2023.

Storage is the unglamorous lever. Latex degrades in heat — a condom in a wallet across a summer or in a glove compartment is already compromised before it gets opened. Kept in a cool drawer, they last to their printed expiration of three to five years. Position matters too: the condom that is in the bedside drawer gets used; the one in the coat pocket across the room often doesn't.

What changes when this is just the routine

Within a week or two. The day-after pregnancy check stops having a rationale. The late-period spiral has a thinner trigger. The intrusive should-I-have-used-something thought that used to run an hour after sex loses its hook. None of these is dramatic; they are the quiet disappearance of background friction the reader had stopped noticing they were paying.

Within a few months, for the reader switching from hormonal contraception, the natural cycle returns within weeks and the rest follows on its own schedule. Some users report a libido lift they only register in retrospect — a thing they did not realise was gone until it came back. A real share report a mood floor lifting around the second or third month. The population-magnitude evidence on hormonal-contraceptive mood effects is mixed; the individual experience, when it lands, is unmistakable.

Across the years, the differences are small per year and large in aggregate. The chlamydia or gonorrhea that would have ascended into pelvic inflammatory disease doesn't. The persistent HPV exposure that would have shown up as cervical dysplasia on a screen a decade later mostly doesn't either. For readers in higher-prevalence networks, the HIV exposure that would have changed the shape of a life doesn't arrive. The payoff is largely the silence of things that never happened — which is a real payoff, even if it is hard to picture.

The two-partner version. In the early months of a new relationship, the question is this person safe rides under every act, half-answered by social proof. Barriers plus both partners running a recent panel collapse the question. The trust gets to be about other things.

Adjacent topics this entry doesn't cover but readers often want next: hormonal contraception (the pill, ring, patch, shot, implant) and the long-acting non-hormonal copper IUD; pre-exposure prophylaxis (PrEP) for HIV; the HPV vaccine (the only intervention that beats the condom on HPV coverage); fertility-awareness methods; emergency contraception; routine STI screening cadence and the actual window periods for each test. The decision to layer barriers with one or more of those — rather than choose among them — is the modern shape of the choice.

·
609